Furthermore, Gilkes and colleagues recently demonstrated that the metastatic marker PLOD2 is a hypoxia-inducible gene and is required for breast cancer metastasis to lymph and lung [41]. This evidence concerns the gene PLOD2 and breast carcinoma.